Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ann Marie Navar Boggan"'
Autor:
Michelle M. Hughes, Saad B. Omer, William K.Y. Pan, Ann Marie Navar-Boggan, Walter Orenstein, Edgar K. Marcuse, James Taylor, M. Patricia DeHart, Terrell C. Carter, Anthony Damico, Neal Halsey, Daniel A. Salmon
Publikováno v:
Vaccines, Vol 1, Iss 2, Pp 154-166 (2013)
Rates of delay and refusal of recommended childhood vaccines are increasing in many U.S. communities. Children’s health care providers have a strong influence on parents’ knowledge, attitudes, and beliefs about vaccines. Provider attitudes toward
Externí odkaz:
https://doaj.org/article/db16d81d7132430cb96652a269842583
Autor:
Michael J. Pencina, Ralph B. D'Agostino, Allan D. Sniderman, Ann Marie Navar-Boggan, Eric D. Peterson
Publikováno v:
Journal of the American College of Cardiology. 65:1633-1639
Background New cholesterol guidelines emphasize 10-year risk of cardiovascular disease (CVD) to identify adults eligible for statin therapy as primary prevention. Whether these CVD risk thresholds should be individualized by age and sex has not been
Autor:
Allan D. Sniderman, Ann Marie Navar-Boggan, Benjamin Neely, Eric D. Peterson, Ralph B. D'Agostino, Michael J. Pencina
Publikováno v:
Circulation. 131:451-458
Background— Many young adults with moderate hyperlipidemia do not meet statin treatment criteria under the new American Heart Association/American College of Cardiology cholesterol guidelines because they focus on 10-year cardiovascular risk. We ev
Autor:
Eric D. Peterson, Christopher P. Danford, Judy Stafford, Catherine McCarver, Tracy Y. Wang, Ann Marie Navar-Boggan
Publikováno v:
American Heart Journal. 166:701-708
Background Over the past decade, electronic health records (EHRs) have emerged as a potential tool to assess quality of care; however, the feasibility and accuracy of EHRs to assess adherence to lipid management performance measures have not been eva
Autor:
Walter A. Orenstein, James G. Taylor, M. Patricia deHart, Terrell Carter, Michelle J. Mergler, Saad B. Omer, William Pan, Daniel A. Salmon, Ann Marie Navar-Boggan, Edgar K. Marcuse, Anthony Damico, Neal A. Halsey
Publikováno v:
Vaccine. 31:4591-4595
Objectives Health care providers influence parental vaccination decisions. Over 90% of parents report receiving vaccine information from their child's health care provider. The majority of parents of vaccinated children and children exempt from schoo
Publikováno v:
American Heart Journal. 165:823-827
Background Definitions of multiple performance measures exist for the assessment of blood pressure control; however, limited data on how these technical variations may affect actual measured performance are available. Methods We evaluated patients wi
Publikováno v:
Pediatrics. 130:e615-e622
OBJECTIVE: Duke University Health System (DUHS) generates annual antibiograms combining adult and pediatric data. We hypothesized significant susceptibility differences exist for pediatric isolates and that distributing these results would alter anti
Autor:
Ralph B. D'Agostino, Ann Marie Navar-Boggan, Michael J. Pencina, Benjamin Neely, Eric D. Peterson, Allan D. Sniderman
Publikováno v:
Circulation. 132
We thank Dr Hayward for his interest in our article.1 First, we note that our study was not intended to negate a risk-based approach to statin therapy. In fact, some of us have pioneered and led multiple efforts in the development of risk prediction
Autor:
Chan Mi Park, Min Jung Ko, Woo Je Lee, Michael J. Pencina, Duk-Woo Park, Sun Mi Lee, Ann Marie Navar-Boggan, Yun Jung Kim
Publikováno v:
American heart journal. 170(3)
Background The applicability to different race/ethnic groups and effects on cardiovascular disease (CVD) outcomes of the 2013 American College of Cardiology and American Heart Association (ACC/AHA) guidelines for cholesterol management remain to be d
Autor:
Ann Marie, Navar-Boggan, Eric D, Peterson, Ralph B, D'Agostino, Michael J, Pencina, Allan D, Sniderman
Publikováno v:
Journal of the American College of Cardiology. 65(16)
New cholesterol guidelines emphasize 10-year risk of cardiovascular disease (CVD) to identify adults eligible for statin therapy as primary prevention. Whether these CVD risk thresholds should be individualized by age and sex has not been explored.Th